Regulatory Exclusivity: NEW PRODUCT
✉ Email this page to a colleague
Drugs with New Product Regulatory Exclusivity
Click here to include patents covering these drugs in this list
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Exclusivity Expiration | Patented / Exclusive Use |
---|---|---|---|---|---|---|---|---|---|---|---|
Pf Prism Cv | VFEND | voriconazole | FOR SUSPENSION;ORAL | 021630-001 | Dec 19, 2003 | AB | RX | Yes | Yes | See Plans and Pricing | NEW PATIENT POPULATION |
Pf Prism Cv | VFEND | voriconazole | INJECTABLE;INTRAVENOUS | 021267-001 | May 24, 2002 | AP | RX | Yes | Yes | See Plans and Pricing | NEW PATIENT POPULATION |
Pf Prism Cv | VFEND | voriconazole | TABLET;ORAL | 021266-001 | May 24, 2002 | AB | RX | Yes | No | See Plans and Pricing | NEW PATIENT POPULATION |
Pf Prism Cv | VFEND | voriconazole | TABLET;ORAL | 021266-002 | May 24, 2002 | AB | RX | Yes | Yes | See Plans and Pricing | NEW PATIENT POPULATION |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Exclusivity Expiration | >Patented / Exclusive Use |